Bangkok Genomics Innovation PCL

Bangkok Genomics Innovation PCL EBIT Margin

The EBIT Margin (Operating Margin) of Bangkok Genomics Innovation PCL (BKGI.BK) as of Oct 31, 2026 is 11.17 %. In the previous year, EBIT Margin (Operating Margin) was 15.95 % — a change of -29.96% (lower).

EBIT Margin

11.17 %

YoY

-29.96%

Last updated:

EBIT Margin (Operating Margin) of Bangkok Genomics Innovation PCL is 2025 11.17 % . EBIT Margin (Operating Margin) of Bangkok Genomics Innovation PCL was 2024 15.95 % . It decreases by -29.96% lower compared to the previous year.

Bangkok Genomics Innovation PCL's operating (EBIT) margin stands at 11.2%, down from 28.1% several years earlier.

The Bangkok Genomics Innovation PCL EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-19.58 THB
Jan 1, 2019
10.67 THB
Jan 1, 2020
10.32 THB
Jan 1, 2021
28.11 THB
Jan 1, 2022
26.16 THB
Jan 1, 2023
13.38 THB
Jan 1, 2024
15.95 THB
Jan 1, 2025
11.17 THB
The Bangkok Genomics Innovation PCL EBIT Margin history
YEAREBIT MarginYoY
11.17 %-29.96%
15.95 %+19.20%
13.38 %-48.85%
26.16 %-6.93%
28.11 %+172.47%
10.32 %-3.28%
10.67 %-154.47%
-19.58 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bangkok Genomics Innovation PCL Stock analysis

What does Bangkok Genomics Innovation PCL do? Bangkok Genomics Innovation PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bangkok Genomics Innovation PCL stock

EBIT Margin (Operating Margin) of Bangkok Genomics Innovation PCL is 11.17 % in 2025.

EBIT Margin (Operating Margin) of Bangkok Genomics Innovation PCL changed from 15.95 % to 11.17 %, representing a -29.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Bangkok Genomics Innovation PCL since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Bangkok Genomics Innovation PCL with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Bangkok Genomics Innovation PCL

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Bangkok Genomics Innovation PCL